Viva Biotech Holdings (VB0) — Strategic Asset Allocation Index
Viva Biotech Holdings (VB0) has a Strategic Asset Allocation Index of 52.6% as of June 2023. Strategic assets (PP&E of €1.91 Billion plus long-term investments of €-) total €1.91 Billion, measured against net assets of €3.64 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Viva Biotech Holdings Strategic Asset Allocation Index (2016–2021)
This chart shows how Viva Biotech Holdings's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of June 2023, the index stands at 52.6%, representing strategic assets of €1.91 Billion against net assets of €3.64 Billion EUR. Explore cash efficiency ratio of Viva Biotech Holdings to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Viva Biotech Holdings (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Viva Biotech Holdings from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see VB0 stock market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 44.1% | €1.72 Billion | €1.72 Billion | €- | €3.91 Billion | ▲ +24.4 pp |
| 2020 | 19.6% | €737.01 Million | €737.01 Million | €- | €3.76 Billion | ▲ +10.8 pp |
| 2019 | 8.8% | €156.99 Million | €156.99 Million | €- | €1.78 Billion | ▼ -17.8 pp |
| 2018 | 26.6% | €66.90 Million | €66.90 Million | €- | €251.44 Million | ▲ +4.1 pp |
| 2017 | 22.5% | €34.40 Million | €34.40 Million | €- | €152.76 Million | ▼ -5.4 pp |
| 2016 | 27.9% | €21.34 Million | €21.34 Million | €- | €76.50 Million | — |